Isn't Calliden still sitting on a bucketload of surplus franking credits? Would some kind of off-market buyback that included a dividend be an option?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025